Capital DailyCapital Daily
Finance

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.

This big pharma stock looks attractive for income investors -- but it comes with some risk.

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.

Published July 6, 2026 · Category: Finance

Overview

Bristol Myers Squibb (NYSE: BMY) belongs to an elite group. Only two other large-cap healthcare stocks offer higher dividend yields. Bristol Myers Squibb's juicy yield of 4.3% is absolutely grabbing the attention of many income investors.

The drugmaker has paid a dividend for an impressive 94 consecutive years. Bristol Myers Squibb has increased its dividend for 17 straight years. But is its dividend safe now? Here's what investors need to know.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.